Beigene Stock

Beigene Employees 2024

Beigene Employees

5,300

Ticker

6160.HK

ISIN

KYG1146Y1017

WKN

A144EN

In 2024, Beigene employed 5,300 people, a 0% change from the 5,300 number of employees in the previous year.

Beigene Aktienanalyse

What does Beigene do?

Beigene Ltd is a Chinese biotech company that is active in cancer research. It was founded in 2010 by experienced biotech manager John Oyler. The company is now listed on NASDAQ and also has a presence in the United States. Beigene's business model is to develop and distribute innovative cancer treatments. The company utilizes its extensive expertise in molecular and cellular biology as well as clinical development. The goal is to develop therapies that specifically target tumor cells while sparing healthy tissue. This is intended to improve patient survival rates and quality of life. Beigene specializes in the development of cancer treatments, particularly immunotherapies and precision medicine. The latter utilizes targeted attacks against tumor cells at the molecular level to achieve the most focused and effective treatment possible. The company focuses primarily on rare tumor types for which there are currently few or no effective therapies. Beigene is divided into several divisions that focus on different treatment approaches. One important division is immunotherapies, which activate the patient's own immune system against the tumor. Beigene develops antibodies, for example, that recognize and attack specific tumor cells. CAR-T cell therapy is also part of the company's portfolio. In this approach, the patient's T cells are harvested, genetically modified, and multiplied in the laboratory. These T cells are then reintroduced into the patient's body, where they target the tumor specifically. Another division of Beigene is the so-called small molecule drugs. These are chemical compounds that are introduced into the body and specifically attack tumor cells. Beigene develops inhibitors, for example, that inhibit specific enzymes and thus suppress the growth of cancer cells. Beigene has been particularly successful with its drug Zanubrutinib, which is used to treat lymphomas. The drug has achieved excellent results in clinical trials and has already been approved in several countries. Overall, Beigene is an innovative and promising biotech company that specializes in the development of new cancer treatments. The company has a strong expertise in molecular biology and has already achieved promising successes. With its various divisions and products, Beigene covers a wide range of treatment approaches and is likely to play an important role in the fight against cancer in the future. Beigene ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Beigene's Employee Base

Beigene's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Beigene's operational capacity and future potential.

Year-to-Year Comparison

Assessing Beigene's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Beigene's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Beigene’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Beigene stock

How many employees does Beigene have this year?

Beigene has 5,300 undefined employees this year.

How many employees did Beigene have compared to the previous year?

Compared to the previous year, Beigene had 0% more employees.

What impact did the number of employees have on the company Beigene?

The number of employees has a direct impact on the efficiency and productivity of Beigene. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Beigene?

The number of employees can also have an impact on investors of Beigene, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Beigene affect the company?

An increase in equity of Beigene can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Beigene's equity affect the company?

A reduction in equity of Beigene can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Beigene?

Some factors that can influence the equity of Beigene include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Beigene so important for investors?

The equity of Beigene is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Beigene influence the company?

The number of employees at Beigene can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Beigene evolved in recent years?

In recent years, the number of employees at Beigene has changed by 0.

How many employees does Beigene currently have?

Beigene currently has 5,300 undefined employees.

Why is the number of employees important for investors of Beigene?

The number of employees is important for investors of Beigene as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Beigene take to change the number of employees?

To change the number of employees, Beigene can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Beigene pay?

Over the past 12 months, Beigene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Beigene is expected to pay a dividend of 0 USD.

What is the dividend yield of Beigene?

The current dividend yield of Beigene is .

When does Beigene pay dividends?

Beigene pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Beigene?

Beigene paid dividends every year for the past 0 years.

What is the dividend of Beigene?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Beigene located?

Beigene is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beigene kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beigene from 11/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Beigene pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Beigene in the year 2023?

In the year 2023, Beigene distributed 0 USD as dividends.

In which currency does Beigene pay out the dividend?

The dividends of Beigene are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beigene

Our stock analysis for Beigene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beigene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.